BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15794383)

  • 21. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.
    Giannetti P; Politis M; Su P; Turkheimer F; Malik O; Keihaninejad S; Wu K; Reynolds R; Nicholas R; Piccini P
    Neurobiol Dis; 2014 May; 65():203-10. PubMed ID: 24508617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
    Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
    Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron Emission Tomography with [
    Hamzaoui M; Garcia J; Boffa G; Lazzarotto A; Absinta M; Ricigliano VAG; Soulier T; Tonietto M; Gervais P; Bissery A; Louapre C; Bottlaender M; Bodini B; Stankoff B
    Ann Neurol; 2023 Aug; 94(2):366-383. PubMed ID: 37039158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo measurement of activated microglia in dementia.
    Cagnin A; Brooks DJ; Kennedy AM; Gunn RN; Myers R; Turkheimer FE; Jones T; Banati RB
    Lancet; 2001 Aug; 358(9280):461-7. PubMed ID: 11513911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
    Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
    Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL
    J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
    Politis M; Giannetti P; Su P; Turkheimer F; Keihaninejad S; Wu K; Waldman A; Malik O; Matthews PM; Reynolds R; Nicholas R; Piccini P
    Neurology; 2012 Aug; 79(6):523-30. PubMed ID: 22764258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial activation in young adults with autism spectrum disorder.
    Suzuki K; Sugihara G; Ouchi Y; Nakamura K; Futatsubashi M; Takebayashi K; Yoshihara Y; Omata K; Matsumoto K; Tsuchiya KJ; Iwata Y; Tsujii M; Sugiyama T; Mori N
    JAMA Psychiatry; 2013 Jan; 70(1):49-58. PubMed ID: 23404112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.
    Kannan S; Saadani-Makki F; Balakrishnan B; Chakraborty P; Janisse J; Lu X; Muzik O; Romero R; Chugani DC
    Dev Neurosci; 2011; 33(3-4):231-40. PubMed ID: 21791891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis.
    Laaksonen S; Saraste M; Sucksdorff M; Nylund M; Vuorimaa A; Matilainen M; Heikkinen J; Airas L
    Mult Scler Relat Disord; 2023 Jul; 75():104755. PubMed ID: 37216883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
    Janardhan V; Suri S; Bakshi R
    Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.
    Wiley CA; Lopresti BJ; Becker JT; Boada F; Lopez OL; Mellors J; Meltzer CC; Wisniewski SR; Mathis CA
    J Neurovirol; 2006 Aug; 12(4):262-71. PubMed ID: 16966217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal thinning of the cerebral cortex in multiple sclerosis.
    Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
    Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke.
    Gerhard A; Neumaier B; Elitok E; Glatting G; Ries V; Tomczak R; Ludolph AC; Reske SN
    Neuroreport; 2000 Sep; 11(13):2957-60. PubMed ID: 11006973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
    Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.